Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,800
Closed -$2K 5285
2021
Q3
$2K Sell
5,800
-5,100
-47% -$16.1K ﹤0.01% 4947
2021
Q2
$1K Buy
10,900
+6,900
+173% +$22.5K ﹤0.01% 5178
2021
Q1
$1K Buy
+4,000
New +$11.3K ﹤0.01% 5103
2020
Q4
Sell
-20,000
Closed -$5K 4712
2020
Q3
$5K Sell
20,000
-25,000
-56% -$62.7K ﹤0.01% 3444
2020
Q2
$3K Buy
+45,000
New +$106K ﹤0.01% 3550
2019
Q1
Sell
-4,400
Closed -$5K 3931
2018
Q4
$5K Buy
4,400
+2,200
+100% +$9.39K ﹤0.01% 2890
2018
Q3
$1K Buy
+2,200
New +$10.5K ﹤0.01% 3676
2017
Q2
Sell
-12,500
Closed -$1K 6261
2017
Q1
$1K Buy
+12,500
New +$68.6K ﹤0.01% 5721
2016
Q1
Sell
-9,000
Closed -$5K 6381
2015
Q4
$5K Buy
+9,000
New +$44K ﹤0.01% 4839

Other funds holding ABEV

Cutler Group's ABEV Position: Q4 2022 in Review

Cutler Group sold out of Ambev (ABEV) in Q4 2022, closing a stake of 500 shares — an estimated $1.46K sold.

Cutler Group first reported a position in ABEV in Q4 2015 and held it in 22 quarters. The position peaked at $131K in Q3 2016. 314 funds tracked by Wall St. Rank hold ABEV as of Q4 2022.

  • Cutler Group reported no remaining Ambev position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 500 Ambev shares in Q4 2022, an estimated $1.46K.
  • Cutler Group first reported a position in Ambev in Q4 2015 and held it in 22 quarters.
  • Cutler Group's Ambev position peaked at $131K in Q3 2016.
  • 314 funds tracked by Wall St. Rank held Ambev as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.